The 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain was released on 28 October 2021. This report represents years of work by the Joint Committee on Clinical Practice Guidelines to define protocols and algorithms based on the evidence.
- Clinical Validation of DEEPVESSEL® FFR: AI CT-FFR Analysis by Keya Medical
- TARGET Randomized On-Site CT FFR Trial Results
- Keya Medical’s CT FFR analysis DEEPVESSEL® is now available in the USA.
- The future of AI-driven, noninvasive CT FFR technology-DeepVessel FFR at 2022 cardiology events in China
- DEEPVESSEL FFR, Keya Medical Deep-Learning Based, Non-Invasive Coronary Artery Functional Assessment Software Device, Receives FDA Clearance.